Pest managers are 30 years ahead of oncologists:
Robert Gatenby, the co-founder of Florida-based Moffitt Cancer Center’s new Center of Excellence for Evolutionary Therapy, is a pioneer in the field and driving the bulk of the work in the U.S. on adaptive therapy. He is also a co-author on a small, pilot study, with initial results published in 2017 in Nature Communications, that showed that patients lasted at least 27 months on average without their tumors growing, compared with the usual 16.5 months, while receiving less of the same drug.
Dr. Gatenby, who had a background in physics before going into medicine, often points to pest control to describe therapy, and others in the field have picked up the analogy as well. In pest management, managers often don’t try to eliminate all of the insects but instead reduce their numbers, keeping the spray-sensitive bugs around to compete against the resistant bugs. Pest management developed the technique after overusing insecticides, which eliminated most of the insects. But some resistant bugs came crawling back.
Cool.
One of those genius ideas that was completely opaque until you’ve heard of it and then… it’s totally obvious.
What did the competing species of the cancer use? …fight over metabolic systems, fight over angiogenesis, fight over transcription resources..? just spitballing….
Might want to save this link in case you ever get cancer.
http://www.rexresearch.com/fenbendazole/fenbendazole.html
Look at the links at this link. This is actually the kind of stuff the Centers of Disease Control should be looking at because no one is going to pay to test this like any other drug. Right now the CDC is just another government captured bureaucracy this time captured by the drug companies.
There’s no money in this. Cancer drugs are stupendously priced. If you could cure a vast amount of cancers with a few hundred bucks worth of drugs it would really kick the cancer doctors and drug companies in the pocketbook.